A2B adenosine receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07741331

ABSTRACT:
Disclosed are novel A2Badenosine receptor antagonists having the structure of Formula I or Formula II:The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.

REFERENCES:
patent: 5776940 (1998-07-01), Daluge et al.
patent: 6117878 (2000-09-01), Linden
patent: 6825349 (2004-11-01), Kalla et al.
patent: 6894021 (2005-05-01), Belardinelli et al.
patent: 7304070 (2007-12-01), Kalla et al.
patent: 7317017 (2008-01-01), Kalla et al.
patent: 7579348 (2009-08-01), Wang et al.
patent: 2003/0207879 (2003-11-01), Baraldi et al.
patent: 2006/0293283 (2006-12-01), Kalla et al.
patent: 2007/0219221 (2007-09-01), Zeng et al.
patent: 2008/0153856 (2008-06-01), Kalla et al.
patent: 2008/0194593 (2008-08-01), Kalla et al.
patent: 2008/0318983 (2008-12-01), Kalla et al.
patent: 2009/0298744 (2009-12-01), Palle et al.
The MDAdvice.com entry for Asthma <http://www.mdadvice.com/topics/asthma/info/1.htm downloaded from the Internet Aug. 31, 2009.
Mazur, Farmatsevtichnii Zh. 1996 (3) 82-84.
Priimenko, Ukrainskii Khimicheskii Zh. 62(7-8) 121-124.
Klosa, Arch. Pharm. 1956 289, 211-217.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

A2B adenosine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A2B adenosine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A2B adenosine receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4197908

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.